BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3277204)

  • 1. New diagnostic tests for assessing coronary heart disease risk.
    Naito HK
    Prog Clin Biol Res; 1988; 255():49-62. PubMed ID: 3277204
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of lipid and lipoprotein profiles in risk assessment and therapy.
    Ballantyne CM; Hoogeveen RC
    Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study.
    Canouï-Poitrine F; Luc G; Bard JM; Ferrieres J; Yarnell J; Arveiler D; Morange P; Kee F; Evans A; Amouyel P; Ducimetiere P; Empana JP;
    Cerebrovasc Dis; 2010 Aug; 30(3):252-9. PubMed ID: 20664258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid determination in current medical practice].
    Bakir R; Chanu B; Rouffy J
    Ann Dermatol Venereol; 1986; 113(9):855-9. PubMed ID: 3827091
    [No Abstract]   [Full Text] [Related]  

  • 5. Triglycerides and coronary artery disease.
    Sum CF; Tan CE; Wang KW
    Singapore Med J; 1992 Oct; 33(5):443-5. PubMed ID: 1455264
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipid profile in 4 minutes. Impressing your coronary heart disease patients].
    Janssen K
    MMW Fortschr Med; 2000 Jul; 142(26-27):39. PubMed ID: 10929482
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum lipids of alcoholics before and following abstinence. Significance for coronary risk].
    Clemens MR; Schied HW; Waller HD
    J Clin Chem Clin Biochem; 1986 Jun; 24(6):369-74. PubMed ID: 3746201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein analysis.
    Colyar MR
    Adv Nurse Pract; 2002 May; 10(5):30-2. PubMed ID: 12420528
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
    Onat A
    Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
    Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL-cholesterol and HDL-cholesterol in ischaemic heart disease.
    Atukorala TM; Gunarathna PH; Ekanayake RA; Wijayawardhana UD
    Ceylon Med J; 1986 Mar; 31(1):9-14. PubMed ID: 3802308
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoproteins as predictors of ischemic heart disease in non-insulin-dependent diabetic men.
    Barrett-Connor E; Philippi T; Khaw KT
    Am J Prev Med; 1987; 3(4):206-10. PubMed ID: 3452358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of apolipoproteins is better than routinely measured traditional lipids].
    Kallner A; Estonius M
    Lakartidningen; 2006 Mar 8-14; 103(10):753-6, 758. PubMed ID: 16610202
    [No Abstract]   [Full Text] [Related]  

  • 16. Reverse cholestrol transport substantially influences the individual risk of coronary heart disease in hypercholesterolaemic patients.
    Poledne R; Rosolová H
    Eur Heart J; 2001 Mar; 22(6):442-3. PubMed ID: 11237535
    [No Abstract]   [Full Text] [Related]  

  • 17. Joint effects of serum triglycerides and LDL and HDL cholesterol.
    Avins AL; Hulley SB
    Circulation; 1993 Jan; 87(1):300-1. PubMed ID: 8419022
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnostic value of lipids and apolipoproteins for assessment of atherogenic risk].
    Herrmann W; Hanf S; Schütz C; Lindhofer HG; Schmidt H; Strauss HJ; Schaedel H; Oswald B
    Z Gesamte Inn Med; 1988 Feb; 43(4):86-92. PubMed ID: 3376506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL testing should be routine part of assessments of coronary heart disease risk, says consensus panel.
    Clin Pharm; 1992 May; 11(5):378, 381. PubMed ID: 1582128
    [No Abstract]   [Full Text] [Related]  

  • 20. [The importance of triglycerides and HDL cholesterol as coronary disease risk factors].
    Nikkilä M; Niemelä K; Koivula T; Sisto T
    Duodecim; 1989; 105(15):1307-12. PubMed ID: 2791916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.